ClearPoint Neuro (CLPT) Income from Continuing Operations (2011 - 2026)
ClearPoint Neuro's (CLPT) quarterly Income from Continuing Operations came in at 9552000.0 in Q1 2026, down 58.51% year-on-year from 23024140.8 in Q1 2025, and down 22.68% quarter-over-quarter from 7786000.0 in Q4 2025.
ClearPoint Neuro (CLPT) Income from Continuing Operations (2011 - 2026) Analysis & Trends
ClearPoint Neuro has disclosed Income from Continuing Operations across 15 years of filings, most recently posting 9552000.0 for Q1 2026.
- Income from Continuing Operations for Q1 2026 came in at 9552000.0, down 58.51% year-over-year; the trailing twelve-month figure through Mar 2026 was 29066000.0 (down 39.78% YoY), and the FY2025 annual result was 25540000.0, down 35.03% from the prior year.
- Income from Continuing Operations came in at 9552000.0 for Q1 2026 at ClearPoint Neuro, down from 7786000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 3795000.0 in Q3 2022 to a low of 9552000.0 in Q1 2026.
- The 5-year median for Income from Continuing Operations is 4974000.0 (2024), against an average of 5469470.59.
- Across the five-year window, Income from Continuing Operations slumped 66.03% in 2023 and jumped 38.19% in 2024, its largest moves.
- ClearPoint Neuro's Income from Continuing Operations stood at 4469000.0 in 2022, then retreated by 5.3% to 4706000.0 in 2023, then dropped by 14.45% to 5386000.0 in 2024, then plunged by 44.56% to 7786000.0 in 2025, then slipped by 22.68% to 9552000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 9552000.0 (Q1 2026), 7786000.0 (Q4 2025), and 5891000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | ClearPoint Neuro | 524.46 Mn | 488.86 Mn | 7.76 Mn | -9.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.55 Mn |
| Dec 31, 2025 | -7.79 Mn |
| Sep 30, 2025 | -5.89 Mn |
| Jun 30, 2025 | -5.84 Mn |
| Mar 31, 2025 | -6.03 Mn |
| Dec 31, 2024 | -5.39 Mn |
| Sep 30, 2024 | -4.97 Mn |
| Jun 30, 2024 | -4.41 Mn |
| Mar 31, 2024 | -4.15 Mn |
| Dec 31, 2023 | -4.71 Mn |
| Sep 30, 2023 | -4.90 Mn |
| Jun 30, 2023 | -7.13 Mn |
| Mar 31, 2023 | -5.71 Mn |
| Dec 31, 2022 | -4.47 Mn |
| Sep 30, 2022 | -3.80 Mn |
| Jun 30, 2022 | -4.30 Mn |
| Mar 31, 2022 | -3.97 Mn |
| Dec 31, 2021 | -4.15 Mn |
| Sep 30, 2021 | -4.04 Mn |
| Jun 30, 2021 | -3.65 Mn |